Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Jun;1(2):138-51.
doi: 10.1007/s11481-006-9011-9.

Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS

Marcus Kaul  1 , Stuart A Lipton
Affiliations
Review

Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS

Marcus Kaul et al. J Neuroimmune Pharmacol. 2006 Jun.

Abstract

Infection with the human immunodeficiency virus-1 (HIV-1) and acquired immunodeficiency syndrome (AIDS) are a persistent health problem worldwide. HIV-1 seems to enter the brain very soon after peripheral infection and can induce severe and debilitating neurological problems that include behavioral abnormalities, motor dysfunction, and frank dementia. Infected peripheral immune-competent cells, in particular macrophages, appear to infiltrate the CNS and provoke a neuropathological response involving all cell types in the brain. The course of HIV-1 disease is strongly influenced by viral and host factors, such as the viral strain and the response of the host's immune system. In addition, HIV-1-dependent disease processes in the periphery have a substantial effect on the pathological changes in the central nervous system (CNS), although the brain eventually harbors a distinctive viral population of its own. In the CNS, HIV-1 also incites activation of chemokine receptors, inflammatory mediators, extracellular matrix-degrading enzymes, and glutamate receptor-mediated excitotoxicity, all of which can initiate numerous downstream signaling pathways and disturb neuronal and glial function. Although there have been many major improvements in the control of viral infection in the periphery, an effective therapy for HIV-1-associated dementia (HAD) is still not available. This article addresses recently uncovered pathologic neuroimmune and degenerative mechanisms contributing to neuronal damage induced by HIV-1 and discusses experimental and potentially future therapeutic approaches.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Am J Pathol. 1995 May;146(5):1121-30 - PubMed
    1. Annu Rev Med. 1999;50:425-40 - PubMed
    1. J Virol. 1999 Feb;73(2):897-906 - PubMed
    1. J Neurosci. 2004 Oct 27;24(43):9531-40 - PubMed
    1. Can J Neurol Sci. 2002 Feb;29(1):19-32 - PubMed

Publication types

MeSH terms

LinkOut - more resources